179 related articles for article (PubMed ID: 36324113)
1. Methadone switching for refractory cancer pain.
Ding H; Song Y; Xin W; Sun J; Zhong L; Zhou Q; He C; Gong L; Fang L
BMC Palliat Care; 2022 Nov; 21(1):191. PubMed ID: 36324113
[TBL] [Abstract][Full Text] [Related]
2. The role of methadone in cancer-induced bone pain: a retrospective cohort study.
Sulistio M; Wojnar R; Key S; Kwok J; Al-Rubaie Z; Michael N
Support Care Cancer; 2021 Mar; 29(3):1327-1335. PubMed ID: 32627056
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Methadone as a Second-Line Opioid for Cancer Pain in an Outpatient Clinic: A Prospective Open-Label Study.
Porta-Sales J; Garzón-Rodríguez C; Villavicencio-Chávez C; Llorens-Torromé S; González-Barboteo J
Oncologist; 2016 Aug; 21(8):981-7. PubMed ID: 27306912
[TBL] [Abstract][Full Text] [Related]
4. A Comparative Study of Opioid Switching to Methadone for Cancer Pain Control in Successful and Unsuccessful Cases.
Okayama S; Matsuda Y; Yoshikawa Y
J Palliat Med; 2019 Jul; 22(7):844-847. PubMed ID: 30716000
[No Abstract] [Full Text] [Related]
5. Methadone rotation versus other opioid rotation for refractory cancer induced bone pain: protocol of an exploratory randomised controlled open-label study.
Michael N; Sulistio M; Wojnar R; Gorelik A
BMC Palliat Care; 2023 Apr; 22(1):42. PubMed ID: 37059995
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-Related Pain: The EQUIMETH2 Trial (Methadone for Cancer-Related Pain).
Poulain P; Berleur MP; Lefki S; Lefebvre D; Chvetzoff G; Serra E; Tremellat F; Derniaux A; Filbet M;
J Pain Symptom Manage; 2016 Nov; 52(5):626-636.e1. PubMed ID: 27693901
[TBL] [Abstract][Full Text] [Related]
7. Opioid plasma concentrations during a switch from transdermal fentanyl to methadone.
Mercadante S; Villari P; Ferrera P; Casuccio A; Gambaro V
J Palliat Med; 2007 Apr; 10(2):338-44. PubMed ID: 17472504
[TBL] [Abstract][Full Text] [Related]
8. Assistance of a Palliative Care Certified Nurse in the Alleviation of Refractory Cancer Pain by Switching Opioids to Oral Methadone in a Japanese Outpatient Setting.
Okayama S; Matsuda Y
J Hosp Palliat Nurs; 2021 Dec; 23(6):539-543. PubMed ID: 34334770
[TBL] [Abstract][Full Text] [Related]
9. First-line methadone for cancer pain: titration time analysis.
Mammana G; Bertolino M; Bruera E; Orellana F; Vega F; Peirano G; Bunge S; Armesto A; Dran G
Support Care Cancer; 2021 Nov; 29(11):6335-6341. PubMed ID: 33880639
[TBL] [Abstract][Full Text] [Related]
10. Rapid switching between transdermal fentanyl and methadone in cancer patients.
Mercadante S; Ferrera P; Villari P; Casuccio A
J Clin Oncol; 2005 Aug; 23(22):5229-34. PubMed ID: 16051965
[TBL] [Abstract][Full Text] [Related]
11. The role of methadone in opioid rotation-a Polish experience.
Leppert W
Support Care Cancer; 2009 May; 17(5):607-12. PubMed ID: 19043743
[TBL] [Abstract][Full Text] [Related]
12. Methadone prescribed as an analgesic by a specialist palliative medicine team in an acute hospital inpatient setting: retrospective study.
Hayes J; Waldron D; Levins KJ; Gaffney L; Azhar M; Beatty S; Mannion E
BMJ Support Palliat Care; 2024 Jan; 13(e3):e839-e842. PubMed ID: 36104162
[TBL] [Abstract][Full Text] [Related]
13. Methadone as first-line opioid treatment for cancer pain in a developing country palliative care unit.
Peirano GP; Mammana GP; Bertolino MS; Pastrana T; Vega GF; Russo J; Varela G; Vignaroli E; Ruggiero R; Armesto A; Camerano G; Dran G
Support Care Cancer; 2016 Aug; 24(8):3551-6. PubMed ID: 27022964
[TBL] [Abstract][Full Text] [Related]
14. Opioid switching from transdermal fentanyl to oral methadone in patients with cancer pain.
Benítez-Rosario MA; Feria M; Salinas-Martín A; Martínez-Castillo LP; Martín-Ortega JJ
Cancer; 2004 Dec; 101(12):2866-73. PubMed ID: 15529307
[TBL] [Abstract][Full Text] [Related]
15. Switching from oxycodone to methadone in advanced cancer patients.
Mercadante S; Ferrera P; Villari P; Adile C; Casuccio A
Support Care Cancer; 2012 Jan; 20(1):191-4. PubMed ID: 21901297
[TBL] [Abstract][Full Text] [Related]
16. Methadone as a First-Line Opioid in Cancer Pain Management: A Systematic Review.
Mercadante S; Bruera E
J Pain Symptom Manage; 2018 Mar; 55(3):998-1003. PubMed ID: 29101087
[TBL] [Abstract][Full Text] [Related]
17. Switching from methadone to a different opioid: what is the equianalgesic dose ratio?
Walker PW; Palla S; Pei BL; Kaur G; Zhang K; Hanohano J; Munsell M; Bruera E
J Palliat Med; 2008 Oct; 11(8):1103-8. PubMed ID: 18980450
[TBL] [Abstract][Full Text] [Related]
18. Methadone for Pain Management in Children with Cancer.
Habashy C; Springer E; Hall EA; Anghelescu DL
Paediatr Drugs; 2018 Oct; 20(5):409-416. PubMed ID: 30047027
[TBL] [Abstract][Full Text] [Related]
19. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
[TBL] [Abstract][Full Text] [Related]
20. Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit.
Mercadante S; Ferrera P; Villari P; Casuccio A; Intravaia G; Mangione S
J Pain Symptom Manage; 2009 Apr; 37(4):632-41. PubMed ID: 19345298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
